• Citer

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

par Sculier, Jean-Paul ;Lafitte, Jean-Jacques;Paesmans, Marianne ;Thiriaux, Jacques ;Alexopoulos, Constantinos;Baumöhl, J.;Schmerber, Jacqueline ;Koumakis, George;Florin, M.C.;Zacharias, Constantinos;Berghmans, Thierry ;Mommen, Paul;Ninane, Vincent ;Klastersky, Jean
Référence British Journal of Cancer, 83, 9, page (1128-1135)
Publication Publié, 2000

Article révisé par les pairs

• Détails

Titre:	Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
Auteur:	Sculier, Jean-Paul; Lafitte, Jean-Jacques; Paesmans, Marianne; Thiriaux, Jacques; Alexopoulos, Constantinos; Baumöhl, J.; Schmerber, Jacqueline; Koumakis, George; Florin, M.C.; Zacharias, Constantinos; Berghmans, Thierry; Mommen, Paul; Ninane, Vincent; Klastersky, Jean
Informations sur la publication:	British Journal of Cancer, 83, 9, page (1128-1135)
Statut de publication:	Publié, 2000
Sujet CREF:	Cancérologie
	Pneumologie
	Sciences bio-médicales et agricoles
Mots-clés:	Cisplatin
	Non-small cell lung cancer
	Randomized trial
	Stage IV
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0007-0920
	info:scp/0033764530